Abstract
In the treatment of cancer and macular degeneration with photodynamic therapy (PDT), a class of photosensitizing compounds has been developed by a number of drug companies that are either selectively retained in or are preferentially produced by tumor cells.
© 1997 Optical Society of America
PDF ArticleMore Like This
MICHAEL S. PATTERSON
CFP4 Conference on Lasers and Electro-Optics (CLEO:S&I) 1990
Xiaolong Liu
T1B.4 International Conference on Photonics and Imaging in Biology and Medicine (PIBM) 2017
Harubumi Kato
ThL1 Conference on Lasers and Electro-Optics/Pacific Rim (CLEO/PR) 1995